Horizon Discovery Group plc (LSE: HZD), a global leader in the application of gene editing and gene modulation for cell line engineering, today went live with a new website and ecommerce system, marking a significant milestone in the Company’s strategy to fully integrate all tools, technologies and services, including Dharmacon reagents, under the Horizon brand.
Horizon Discovery reaches integration milestone and launches new website
The new website at horizondiscovery.com has been developed to support customers from research to therapy, with new features including:
- improved navigation including sophisticated gene-based search capabilities and advanced filtering
- intuitive, streamlined purchasing and quotation system
- comprehensive, easily accessible technical support and educational content
Terry Pizzie, CEO, Horizon Discovery, said: “Having achieved significant revenue growth this year, the development of the new website and ecommerce system is part of our strategy to fully integrate our cell engineering solutions including our operations, industrialization capability, leadership and management processes, and strengthen our position as a global leader. The functionality of the new website will enable us to more easily recognize and adapt to market and business demands, improving customer engagement and satisfaction, while building value in the Company.”
Horizon Discovery Group plc, a UK headquartered global life science company, is a world leader in gene editing and gene modulation.